CYTR - CytRx Corporation
Previous close
0.092
0 0%
Share volume: 0
Last Updated: Wed 05 Oct 2022 06:00:00 AM CEST
Biological Product (except Diagnostic) Manufacturing :
-3.41%
PREVIOUS CLOSE
CHG
CHG%
$0.09
0.00
0.00%
Summary score
43%
Profitability
44%
Dept financing
50%
Liquidity
46%
Performance
41%
Sector
Manufacturing
Industry
Biological Product (except Diagnostic) Manufacturing
Long-term ratios 2015 - 2019
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-35.62%
Return on assets
-13.8%
Return on sales
0%
Return on invested capital
57.14%
Total debt ratio
49.71%
Debt ratio change over timeo
0.39%
Current Ratio
3.63%
Quick Ratio
0%
Cash Position Ratio
3.07%
Short-term ratios 2018 - 2019
The data are presented for the financials results of the quarters of the last year.
Return on equity
-11.4%
Return on assets
-7.46%
Return on sales
0%
Return on invested capital
55.44%
Total debt ratio
24.1%
Debt ratio change over timeo
0.11%
Current Ratio
5.81%
Quick Ratio
0%
Cash Position Ratio
4.84%
Last quarter ratios 2019
The data are presented for the financials results of the last quarter.
Return on equity
-7.45%
Return on assets
-8.08%
Return on sales
0%
Return on invested capital
61.7%
Total debt ratio
10.97%
Debt ratio change over time
-0.9%
Current Ratio
9.09%
Quick Ratio
0%
Cash Position Ratio
3.82%
Performance ratios (change over 4 years) 2015 - 2019
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-179.02%
Return on assets
-132.96%
Return on sales
0%
Return on invested capital
20.28%
Total debt ratio
38.98%
Debt ratio change over time
0.39%
Current Ratio
7.97%
Quick Ratio
0%
Cash Position Ratio
6.36%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | CYTR | SGEN | NK | SRNG |
|---|---|---|---|---|
| Return on equity | -35.62% | -4.82% | -11.27% | 0% |
| Return on assets | -13.8% | -5.03% | -9.93% | 0% |
| Return on sales | 0% | -40.17% | 0% | 0% |
| Return on invested capital | 57.14% | 390.59% | -28.45% | 0% |
| Profitability | 29% | 25% | 0% | 50% |
| Total debt ratio | 49.71% | 19.16% | 13.75% | 0% |
| Debt ratio change over time | 0.39% | -1.16% | -1.51% | 0% |
| Dept financing | 50% | 10% | 7% | 0% |
| Current Ratio | 5.81% | 3.44% | 4.03% | 0% |
| Quick Ratio | 0% | 3.11% | 0% | 0% |
| Cash Position Ratio | 4.84% | 0.56% | 0.69% | 0% |
| Liquididy | 36% | 44% | 33% | 0% |
| Short-term ratios | CYTR | SGEN | NK | SRNG |
|---|---|---|---|---|
| Return on equity | -11.4% | -2.46% | -13.1% | 0% |
| Return on assets | -7.46% | -3.55% | -10.97% | 0% |
| Return on sales | 0% | -30.98% | 0% | 0% |
| Return on invested capital | 55.44% | -5.09% | -30.14% | 0% |
| Profitability | 50% | 0% | 0% | 50% |
| Total debt ratio | 24.1% | 14.58% | 18.22% | 0% |
| Debt ratio change over time | 0.11% | -1.49% | -1.58% | 0% |
| Dept financing | 50% | 15% | 19% | 0% |
| Current Ratio | 5.81% | 3.44% | 4.03% | 0% |
| Quick Ratio | 0% | 3.11% | 0% | 0% |
| Cash Position Ratio | 4.84% | 0.56% | 0.69% | 0% |
| Liquididy | 50% | 43% | 21% | 0% |